FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

2nd Complete Response Letter on Adamis Zimhi

[ Price : $8.95]

FDA issues Adamis Pharmaceuticals a second complete response letter on its NDA for Zimhi, a high-dose naloxone injection product f...

Draft Guide on Device Electromagnetic Compatibility

[ Price : $8.95]

FDA makes available a draft guidance entitled Electromagnetic Compatibility (EMC) of Medical Devices.

Guide on eFiles for Animal Drug Applications

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance #197 entitled Documenting Electronic Data Files and Statistical Anal...

Complete Response Letter on Sanofi BLA

[ Price : $8.95]

FDA sends Sanofi a complete response letter on its BLA for sutimlimab, an investigational monoclonal antibody for treating hemolys...

Changes Needed for Future Infectious Disease Issues: Woodcock

[ Price : $8.95]

Operation Warp Speeds Janet Woodcock says a lesson learned from the Covid-19 experience is the need to establish infectious diseas...

Heron Resubmits HTX-011 Pain Drug NDA

[ Price : $8.95]

Huron Therapeutics says it has resubmitted to FDA its NDA for HTX-011, an investigational non-opioid analgesic indicated for treat...

FDA Clears Lantheus Bone Scan Index

[ Price : $8.95]

FDA clears the Lantheus automated bone scan index to be used on the GE Healthcare Xeleris platform.

Two Nexus Suits Invoke Buckman Implied Preemption

[ Price : $8.95]

Attorney James Beck says a California federal court dismissed two Nexus Pharmaceutical suits against drug compounders due to impli...

FDA Designates Agios Mitapivat Orphan Drug

[ Price : $8.95]

FDA grants an additional orphan drug designation for Agios mitapavit for treating sickle cell disease.

Indivior Paying $289 Million for Unlawful Suboxone Marketing

[ Price : $8.95]

The Justice Department says Indivior Solutions was sentenced to pay $289 million under a plea agreement for criminal charges invol...